Biomerica
BMRA
6 hedge funds and large institutions have $435K invested in Biomerica in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.
4% more capital invested
Capital invested by funds: $417K → $435K (+$18.3K)
0% less ownership
Funds ownership: 0.16% → 0.16% (-0%)
25% less funds holding
Funds holding: 8 → 6 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$50.9K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$13K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$7.48K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$42K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$24K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$8K |
BMRA Hedge Fund Activity: Q1 2018 in Review
6 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Biomerica (BMRA) for Q1 2018, worth a combined $435K — up 4.4% from $417K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BMRA and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Vanguard Group, adding an estimated $50.9K. The largest seller was Millennium Management, exiting entirely with an estimated $42K sold.
- 6 institutional investors held Biomerica (BMRA) as of Q1 2018, down from 8 in Q4 2017.
- Funds reported $435K of Biomerica stock for Q1 2018, up 4.4% quarter-over-quarter.
- 1 fund opened new Biomerica positions in Q1 2018 and 3 closed out, a net change of -2 holders.
- The largest Biomerica buyer in Q1 2018 was Vanguard Group, an estimated $50.9K added.
- The largest Biomerica seller in Q1 2018 was Millennium Management, an estimated $42K sold.
Based on aggregated 13F filings for Q1 2018.